Search - tctmd.com

Displaying 661 - 680 of 831

Sort: Relevancy | Date

Presentation Aortovascular 2015

Novel Anticoagulants for Venous Thromboembolism: Will this change your practice?

Presenter: Michael R. Jaff

September 18, 2015

Presentation

Impact of Anticoagulation Regimen Prior toRevascularization in Patients With NSTE-ACS

Presenter: Tobias Geisler

September 18, 2015

Presentation

Left Main or Proximal LAD (LM-pLAD) Coronary Artery Disease Location Identifies High-Risk Pts Deriving Potentially Greater Benefit From Prolonged Dual Antiplatelet Therapy (DAPT)

Presenter: F. Costa

August 21, 2015

Presentation

6 Months vs Extended Oral Anticoagulation After a First Episode of Pulmonary Embolism

Presenter: Francis Couturaud

July 10, 2015

Presentation

RE-VERSE AD: Idarucizumab for Dabigatran Reversal

Presenter: Charles V. Pollack Jr

June 24, 2015

Presentation CCVVC 2015

Top 10 Advances of Interventional Cardiology 2014

Presenter: Samin K Sharma

June 17, 2015

Presentation CCVVC 2015

Data for Recent Antiplatelets and Antithrombotics

Presenter: Deepak L. Bhatt

June 17, 2015

Presentation

Concomitant PPI Use, Platelet Activity, and Clinical Outcomes in ACS Patients Treated With Prasugrel vs Clopidogrel and Managed Without Revascularization

Presenter: Jose Carlos Nicolau

June 17, 2015

Presentation

Ticagrelor vs Clopidogrel in Troponin-Negative ACS Patients Undergoing Ad Hoc PCI

Presenter: Roxana Mehran

May 08, 2015

Presentation

Duration of Triple Therapy in Patients Requiring Oral Anticoagulation After DES Implantation

Presenter: K.A. Fiedler

April 22, 2015

Presentation

ACC 2015 Late Breaking Trials: PCI Access and Anticoagulation Trials

Presenter: Gregg W. Stone

April 14, 2015

Presentation CADECI 2015

Uso responsable de Rivaroxabán en prevención secundaria después de un SCA:Casos clínicos_

Presenter: DR. JOSE LUIS LEIVA PONS

February 20, 2015

Presentation CADECI 2015

Importancia De La Terapia Combinada Bajo Las Nuevas Guías Para El Manejo De La Hipertensión Arterial

Presenter: Dr. Enrique G?mez ?lvarez

February 20, 2015

Presentation CADECI 2015

El tratamiento Antiplaquetario Actual en el Síndrome Coronario Agudo ¿Es retornar al Futuro?

Presenter: Dr. Marco Antonio Ramos Corrales

February 20, 2015

Presentation CADECI 2015

Hipertensión Arterial Sistémica: Riesgo Residual

Presenter: Dr. Arturo Guerra L.

February 20, 2015

Presentation CADECI 2015

Controversias en las Guías sobre Hipertensión Arterial JNC 8

Presenter: Dr. Jorge F. Trejo-Guti?rrez

February 20, 2015

Presentation

Association Between the Use of Fondaparinux vs LMWH and Clinical Outcomes in NSTEMI Patients

Presenter: Karolina Szummer

February 19, 2015

Presentation CADECI 2015

Uso responsable de rivaroxabán en prevención secundaria tras un SICA

Presenter: Dr. Carlos Felipe Barrera-Ram?rez

February 19, 2015

Presentation CADECI 2015

Triple Terapia Antitrombótica en Pacientes con Fibrilación Auricular y Enfermedad Coronaria: Beneficio o Amenaza ?

Presenter: Dr. J Antonio Gonz?lez-Hermosillo G

February 19, 2015

Presentation CADECI 2015

Subclinical CV Disease Heart – Brain Integration

Presenter: CADECI 2015

February 19, 2015

Advertisement

Novel Anticoagulants for Venous Thromboembolism: Will this change your practice?

Impact of Anticoagulation Regimen Prior toRevascularization in Patients With NSTE-ACS

Left Main or Proximal LAD (LM-pLAD) Coronary Artery Disease Location Identifies High-Risk Pts Deriving Potentially Greater Benefit From Prolonged Dual Antiplatelet Therapy (DAPT)

6 Months vs Extended Oral Anticoagulation After a First Episode of Pulmonary Embolism

RE-VERSE AD: Idarucizumab for Dabigatran Reversal

Top 10 Advances of Interventional Cardiology 2014

Data for Recent Antiplatelets and Antithrombotics

Concomitant PPI Use, Platelet Activity, and Clinical Outcomes in ACS Patients Treated With Prasugrel vs Clopidogrel and Managed Without Revascularization

Ticagrelor vs Clopidogrel in Troponin-Negative ACS Patients Undergoing Ad Hoc PCI

Duration of Triple Therapy in Patients Requiring Oral Anticoagulation After DES Implantation

ACC 2015 Late Breaking Trials: PCI Access and Anticoagulation Trials

Uso responsable de Rivaroxabán en prevención secundaria después de un SCA:Casos clínicos_

Importancia De La Terapia Combinada Bajo Las Nuevas Guías Para El Manejo De La Hipertensión Arterial

El tratamiento Antiplaquetario Actual en el Síndrome Coronario Agudo ¿Es retornar al Futuro?

Hipertensión Arterial Sistémica: Riesgo Residual

Controversias en las Guías sobre Hipertensión Arterial JNC 8

Association Between the Use of Fondaparinux vs LMWH and Clinical Outcomes in NSTEMI Patients

Uso responsable de rivaroxabán en prevención secundaria tras un SICA

Triple Terapia Antitrombótica en Pacientes con Fibrilación Auricular y Enfermedad Coronaria: Beneficio o Amenaza ?

Subclinical CV Disease Heart – Brain Integration

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content